Efficient Inhibition of the Development of Cardiac Remodeling by a Long-Acting Calcium Antagonist Amlodipine

Hypertension

Volumn 31, Issue 1, 1998, Pages 32-38

  Yamazaki, Tsutomu ^a   Komuro, Issei ^a   Zou, Yunzeng ^a   Kudoh, Sumiyo ^a   Shiojima, Ichiro ^a   Mizuno, Takehiko ^a   Hiroi, Yukio ^a   Nagai, Ryozo ^a   Yazaki, Yoshio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; MYOSIN HEAVY CHAIN; NIFEDIPINE;

ANGINA PECTORIS; ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; DRUG EFFECT; ECHOGRAPHY; GENE EXPRESSION REGULATION; GROWTH REGULATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MALE; MUSCLE DEVELOPMENT; PRIORITY JOURNAL; RAT; SYMPATHETIC REFLEX; SYMPATHETIC TONE;

AMLODIPINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CARDIOMEGALY; COLLAGEN; HEART; HYPERTENSION; MALE; MYOCARDIUM; MYOSIN HEAVY CHAINS; NIFEDIPINE; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 0031916864     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.32     Document Type: Article

References (31)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med. 1990;322:1561-1566.
2. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hypertens. 1992;5:95-110.
3. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326-1331.
4. Burges RA, Dodd MG. Amlodipine. Cardiovasc Drug Rev. 1990;8:25-44.
5. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH, Cropp AB, Demets DL, for the Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med. 1996;335:1107-1114.
6. Nayler WG. The effect of amlodipine on hypertension-induced cardiac hypertrophy and reperfusion-induced calcium overload. J Cardiovasc Pharmacol. 1988;12(suppl 7):S41-S44.
7. Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Y, Wang Y, Mizuno T, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation. 1994;89:2204-2211.
8. Nishimura H, Kubota J, Okabe M, Ueyama M, Kawamura K. Nifedipine in divided doses does not reverse left ventricular hypertension in spontaneously hypertensive rats. Jpn Circ J. 1992;56:255-261.
9. Hoh JF, Mcgrath A, Hale PT. Electrophoresis analysis of multiple form of rat cardiac myosin: effects of hypophysectomy and thyroxine replacement. J Mol Cell Cardiol. 1977;10:1053-1076.
10. Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, Shichiri M, Koike A, Nogami A, Marumo F. Insulin-like growth factor-1 induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation. 1993;87:1715-1721.
11. Genovese C, Rowe D, Kream B. Construction of DNA sequence complementary to rat alpha1 and alpha2 collagen mRNA and their use in studying the regulation of type 1 collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry. 1984;23:6210-6216.
12. Gustafson TA, Markham BE, Morkin E. Analysis of thyroid hormone effects on myosin heavy chain gene expression in cardiac and soleus muscles using a novel dot-blot mRNA assay. Biochem Biophys Res Commun. 1985;130:1161-1167.
13. Komuro I, Kaida T, Shibazaki Y, Kurabayashi M, Takaku F, Yazaki Y. Stretching cardiac myocytes stimulates proto-oncogene expression. J Biol Chem. 1990;265:3595-3598.
14. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi Y, Mizuno T, Maemura K, Kurihara H, Aikawa R, Takano H, Yazaki Y. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem. 1996;271:3221-3228.
15. Komuro I, Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol. 1993;55:55-75.
16. Medugorac I, Jacob R. Characterization of left ventricular collagen in the rat. Cardiovasc Res. 1983;17:15-21.
17. Childs TJ, Adams MA, Mak AS. Regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril and the expression of contractile proteins. Hypertension. 1990;16:662-668.
18. Brilla CG, Janicki JS, Weber KT. Cardioprotective effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation. 1991;83:1771-1779.
19. 2+ -dependent signaling. Circ Res. 1995;76:1-15.
20. Yamazaki T, Tobe K, Hoh E, Maemura K, Kaida T, Komuro I, Tamemoto H, Kadowaki T, Nagai R, Yazaki Y. Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes. J Biol Chem. 1993;268:12069-12076.
21. Donnelly R, Elliott HL, Meredith PA, Kelman AW, Reid JL. Nifedipine: individual responses and concentration-effect relationships. Hypertension. 1988;12:443-449.
22. Abernethy DR, Gutkowska J, Lambert MD. Amlodipine in elderly hypertensive patients: pharmacokinetics and pharmacodynamics. J Cardiovasc Pharmacol. 1988;12(suppl 7):S67-S71.
23. Lund-Johansen P, Omvik P, White W, Digranes O, Helland B, Jordal O, Stray T. Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension. J Hypertens. 1990;8:1129-1136.
24. Donati L, Buhler FR, Beretta-Piccoli C, Kusch F, Heinen G. Antihypertensive mechanism of amlodipine in essential hypertension: role of pressor reactivity to norepinephrine and angiotensin II. Clin Pharmacol Ther. 1992;52:50-59.
25. Marone C, Luisoli S, Bomio F, Beretta-Piccoli C, Bianchetti MG, Weidmann P. Body sodium-blood volume state, aldosterone and cardiovascular responsiveness after calcium entry blockade with nifedipine. Kidney Int. 1985;28:658-665.
26. Morgan HE, Baker KM. Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation. 1991;83:13-25.
27. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83:1849-1865.
28. + -ATPase and bioenergetics of catecholamine storage vesicles. Eur J Pharmacol. 1991;207:37-41.
29. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res. 1991;69:107-115.
30. Kurabayashi M, Tsuchimochi H, Komuro I, Takaku F, Yazaki Y. Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. J Clin Invest. 1988;82:524-531.
31. Tsuchimochi H, Sugi M, Kuro-o M, Ueda S, Takaku F, Furuta S, Shirai T, Yazaki Y. Isozymic changes in myosin of human atrial myocardium induced by overload: immunohistochemical study using monoclonal antibodies. J Clin Invest. 1984;74:662-665.